tiprankstipranks
Advertisement
Advertisement
Sol-Gel Extends Patidegib IP to 2044 and Bolsters Cash Runway With $33.1 Million Offering
PremiumCompany AnnouncementsSol-Gel Extends Patidegib IP to 2044 and Bolsters Cash Runway With $33.1 Million Offering
2M ago
Sol-Gel Technologies Prices $33.1 Million Oversubscribed Equity Offering to Advance SGT-610
Premium
Company Announcements
Sol-Gel Technologies Prices $33.1 Million Oversubscribed Equity Offering to Advance SGT-610
4M ago
Sol-Gel Technologies 459K share Spot Secondary priced at $72.00
Premium
The Fly
Sol-Gel Technologies 459K share Spot Secondary priced at $72.00
4M ago
Sol-Gel: SGT-610 as Core Value Driver Underpins $50 Target and Buy Rating Despite Pipeline Setbacks
PremiumRatingsSol-Gel: SGT-610 as Core Value Driver Underpins $50 Target and Buy Rating Despite Pipeline Setbacks
7M ago
Sol-Gel Technologies Updates Clinical Pipeline Following Phase 1b Results
Premium
Company Announcements
Sol-Gel Technologies Updates Clinical Pipeline Following Phase 1b Results
8M ago
Sol-Gel decides not to advance SGT-210 development in Darier disease
Premium
The Fly
Sol-Gel decides not to advance SGT-210 development in Darier disease
8M ago
Promising Growth and Strategic Financial Moves Make Sol-Gel Technologies a Strong Buy
PremiumRatingsPromising Growth and Strategic Financial Moves Make Sol-Gel Technologies a Strong Buy
9M ago
Sol-Gel Technologies target adjusted to $50 from $6 at H.C. Wainwright
Premium
The Fly
Sol-Gel Technologies target adjusted to $50 from $6 at H.C. Wainwright
9M ago
Sol Gel Technologies trading resumes
Premium
The Fly
Sol Gel Technologies trading resumes
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100